{
    "2020-12-07": [
        [
            {
                "time": "2023-10-10",
                "original_text": "Philip Morris International Announces U.S. Food and Drug Administration Authorization of IQOS 3 for Sale in the United States",
                "features": {
                    "keywords": [
                        "Philip Morris International",
                        "FDA Authorization",
                        "IQOS 3",
                        "U.S. Market"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "tobacco",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "Is There An Opportunity With Philip Morris International Inc.'s (NYSE:PM) 37% Undervaluation?",
                "features": {
                    "keywords": [
                        "Philip Morris International",
                        "undervaluation",
                        "NYSE:PM",
                        "investment opportunity"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "tobacco"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}